Tue, May 1, 2012

by: WOPRAI

NUVASIVE INC (NASDAQ:NUVA), Down By 5.10% ($0.89) From $17.460 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

GENCO SHIPPING & TRADING LIMITED (NYSE:GNK), Down By 9.11% ($0.49) From $5.380 After BUYINS.NET Report Predicted Weakness After

by: WOPRAI

DANAOS CORP (NYSE:DAC), Up By 6.78% ($0.25) From $3.690 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Cond

by: WOPRAI

SOURCEFIRE INC (NASDAQ:FIRE), Up By 10.06% ($4.99) From $49.610 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

Tien-Tsin Huang Maintained (V) at Buy with Increased Target to $37 on, May 1st, 2012

by: WOPRAI

Christopher Raymond Maintained (BIIB) at Buy with Increased Target to $159 on, May 1st, 2012

by: WOPRAI

Jay Olson Maintained (BIIB) at Buy with Increased Target to $139 on, May 1st, 2012

by: WOPRAI

Jeff Kessler Maintained (BCO) at Buy with Increased Target to $33 on, May 1st, 2012

by: WOPRAI

Jay Sole Upgraded (ANF) to Strong Buy and Increased Target to $66 on, May 1st, 2012

by: WOPRAI

Michael Goldsmith Maintained (SPG) at Hold with Increased Target to $158 on, May 1st, 2012

by: WOPRAI

Bret Jordan Maintained (TEN) at Strong Buy with Decreased Target to $38 on, May 1st, 2012

by: WOPRAI

Andy Barish Maintained (TXRH) at Hold with Increased Target to $18 on, May 1st, 2012

by: WOPRAI

Jen Redding Upgraded (AEO) to Buy and Increased Target to $22 on, May 1st, 2012

Mon, April 30, 2012

by: WOPRAI

IOC SqueezeTrigger Price is $60.92. There is $494,630,796 That Short Sellers Still Need To Cover.

by: WOPRAI

WCRX SqueezeTrigger Price is $21.63. There is $62,913,123 That Short Sellers Still Need To Cover.

by: WOPRAI

READING INTERNATIONAL INC-A (NASDAQ:RDI), Up By 5.11% ($0.24) From $4.700 After BUYINS.NET Report Predicted Strength Before Ear

by: WOPRAI

STAN, LTM, ONSM, TPGI, MMP, PRFT Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

MGIC, CHCI, ALLT, DCT, PIP, REED Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

ASTC, NWE, VIST, FDM, ISBC, AMP Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

CCIX, IFON, VRTB, DES, PBIB, CIEN Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

KRO, SHG, NDAQ, DRYS, EXAS, SI Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

CHU, COH, XXIA, SAFM, CHA, LHCG Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

GTE, DAC, CP, MFC, PHX Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

NMR, AMX, TEVA, ECA, EQR, OMN Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

OMCL, CHUX, CAE, FRME, VRNT, JRCC Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

RLOC, MOTR Expected To Be Down After Next Earnings Releases

Christopher Raymond Maintained (BIIB) at Buy with Increased Target to $159 on, May 1st, 2012

Christopher Raymond of Piper Sandler, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $140 to $159 on, May 1st, 2012.

Christopher has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher

  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $140 on, Friday, February 10th, 2012


Similar Stocks and Investing Publications